Tradestie Institutional Equity Comparison Engine

GLPG vs BHVN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GLPG Overall Edge

GLPG Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Galapagos NV (GLPG) driven by superior Valuation, Growth & Margin while BHVN counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, GLPG trades at N/M Forward P/E with 88.0% operating margin (+1093.2% YoY revenue) versus BHVN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, GLPG sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro) against BHVN sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner GLPG
GLPG N/M vs BHVN N/M Fwd P/E
Growth & Margin Winner GLPG
Op Margin 88.0% vs 0.0% ยท YoY +1093.2% vs +0.0%
Momentum & Technical Winner BHVN
1Y +5.6% vs +72.6% ยท 52W Pos 23% vs 59%
Options & Structure Winner BHVN
UNCLASSIFIED (2nd %ile IV) vs CONSOLIDATION (18th %ile IV)
GLPG NASDAQ
Galapagos NV
Pharmaceutical Preparations
$27.73
-3.75% 1D
Market Cap $1.9B
1M Return -4.02%
1Y Return +5.56%
Forward P/E N/M
Unified AI Score
61.5 / 100 BUY
Tech 45.0 Fund 52.0 Flow 50.0 Mom 64.0
BHVN NYSE
Biohaven Ltd.
Pharmaceutical Preparations
$13.95
+0.9% 1D
Market Cap $2.1B
1M Return +29.36%
1Y Return +72.59%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 15.0 Fund 42.0 Flow 68.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GLPG +5.56% BHVN +72.59% Spread: +32.48 pp (BHVN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
GLPG TTM Op. Margin: 88.0% BHVN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GLPG vs BHVN. Trailing 12-month operating profitability (GLPG 88.0% vs BHVN 0.0%) and valuation multiples (GLPG N/M vs BHVN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GLPG (7) vs BHVN (2)
Institutional Metric GLPG BHVN Criterion Row Winner
Market Capitalization Scale $1.9B $2.1B Larger Scale BHVN
Trailing P/E Ratio Valuation 5.1x N/M Lower Multiple GLPG
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +1093.2% +0.0% Higher Growth GLPG
Operating Margin (TTM) Profitability 88.0% 0.0% Higher Margin GLPG
Net Profit Margin Profitability 28.8% 0.0% Higher Margin GLPG
Return on Equity (ROE) Capital Efficiency 10.4% -799.5% Higher ROE GLPG
52-Week Range Position Momentum 23% ($25โ€“$38) 59% ($8โ€“$18) Stronger Trend BHVN
Beta / 30D Volatility Risk Regime 0.71ฮฒ ยท 20% Vol 1.40ฮฒ ยท 111% Vol Lower Realized Risk GLPG
Unified Institutional Score Composite Signal 61.5 / 100 (BUY) 42.1 / 100 (HOLD) Higher Composite GLPG

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GLPG vs BHVN Buy Guide
GLPG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live GLPG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BHVN CONSOLIDATION
91d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live BHVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GLPG nor BHVN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.